O. El-Ahmady

692 total citations
34 papers, 573 citations indexed

About

O. El-Ahmady is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, O. El-Ahmady has authored 34 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in O. El-Ahmady's work include Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). O. El-Ahmady is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Urinary and Genital Oncology Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). O. El-Ahmady collaborates with scholars based in Egypt, Indonesia and Germany. O. El-Ahmady's co-authors include Sanaa Eissa, Abdel‐Baset Halim, Samar K. Kassim, Menha Swellam, Hanan Shehata, Mahmoud Mansour, Omar Mansour, Amal Mansour, Sherif Mourad and Maha Ahmed and has published in prestigious journals such as Cancer, The Journal of Urology and British Journal of Cancer.

In The Last Decade

O. El-Ahmady

33 papers receiving 543 citations

Peers

O. El-Ahmady

SURGE

ONCOL

PRM

G. Fischer Germany

Ikuya Fujiwara Japan

Atsushi Azuma Japan

Y. Hata Japan

Dorenda Oosterhuis Netherlands

C. Decaens France

Linda J. Loretz United States

Steffen Zender Germany

Carolyn A. Goard Canada

Yusuke Nakamura Japan

G. Fischer Germany

O. El-Ahmady

83 ×0.4

SURGE

365 ×1.7

115 ×1.0

ONCOL

89 ×1.1

PRM

159 ×2.1

Citations per year, relative to O. El-Ahmady O. El-Ahmady (= 1×) peers G. Fischer

Countries citing papers authored by O. El-Ahmady

Since Specialization

Citations

This map shows the geographic impact of O. El-Ahmady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. El-Ahmady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. El-Ahmady more than expected).

Fields of papers citing papers by O. El-Ahmady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. El-Ahmady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. El-Ahmady. The network helps show where O. El-Ahmady may publish in the future.

Co-authorship network of co-authors of O. El-Ahmady

This figure shows the co-authorship network connecting the top 25 collaborators of O. El-Ahmady. A scholar is included among the top collaborators of O. El-Ahmady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. El-Ahmady. O. El-Ahmady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eissa, Sanaa, et al.. (2012). Detection of hyaluronidase RNA and activity in urine of schistosomal and non-schistosomal bladder cancer. Medical Oncology. 29(5). 3345–3351. 17 indexed citations

Eissa, Sanaa, Menha Swellam, Samar K. Kassim, et al.. (2011). Aberrant Methylation ofRARβ2andAPCGenes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Nonbilharzial Bladder Cancer. Cancer Epidemiology Biomarkers & Prevention. 20(8). 1657–1664. 38 indexed citations

Eissa, Sanaa, et al.. (2005). Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs. Cancer. 103(7). 1356–1362. 50 indexed citations

Eissa, Sanaa, et al.. (2004). Cell Cycle Regulators in Bladder Cancer: Relationship to Schistosomiasis. IUBMB Life. 56(9). 557–564. 22 indexed citations

Eissa, Sanaa, et al.. (2004). Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma. Clinical Biochemistry. 37(9). 803–810. 22 indexed citations

Eissa, Sanaa, et al.. (2003). Comparison of Telomerase Activity and Matrix Metalloproteinase-9 in Voided Urine and Bladder Wash Samples as a Useful Diagnostic Tool for Bladder Cancer. European Urology. 44(6). 687–694. 30 indexed citations

Eissa, Sanaa, Samar K. Kassim, & O. El-Ahmady. (2003). Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers. Current Opinion in Obstetrics & Gynecology. 15(5). 395–403. 35 indexed citations

El-Ahmady, O., et al.. (2002). Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.. PubMed. 22(4). 2493–9. 20 indexed citations

El-Ahmady, O., et al.. (1999). The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.. PubMed. 19(4A). 2603–8. 10 indexed citations

10.

Zekri, Abdel‐Rahman N., et al.. (1997). Tissue and serum c-erbB-2 and tissue EGFR in breast carcinoma: three years follow-up.. PubMed. 17(4B). 3101–6. 16 indexed citations

11.

Halim, Abdel‐Baset, et al.. (1997). Biochemical Effect of Antioxidants on Lipids and Liver Function in Experimentally-Induced Liver Damage. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(6). 656–663. 109 indexed citations

12.

El-Ahmady, O., et al.. (1997). Elevated Concentrations of Interleukins and Leukotriene in Response to Mycobacterium Tuberculosis Infection. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(2). 160–164. 34 indexed citations

13.

El-Ahmady, O., et al.. (1997). Sonolysis Promotes Indirect Co−C Bond Cleavage of Alkylcob(III)alamin Bioconjugates. Bioconjugate Chemistry. 8(4). 498–502. 22 indexed citations

14.

El-Ahmady, O., et al.. (1996). Urinary gonadotropin peptide (UGP) in Egyptian patients with benign and advanced malignant urological disease. British Journal of Cancer. 73(12). 1486–1490. 5 indexed citations

15.

El-Ahmady, O., et al.. (1996). Comparative study between sonography, pathology and UGP in women with perimenopausal bleeding.. PubMed. 16(4B). 2309–13. 4 indexed citations

16.

Mansour, Mahmoud, et al.. (1994). Elevated Plasma Level of Leukotrienes in Bronchial Asthma Patients: A Possible Clinical Relevance. Disease Markers. 12(2). 117–122. 5 indexed citations

17.

Halim, Abdel‐Baset, et al.. (1994). Urinary β‐HCG in Benign and Malignant Urinary Tract Diseases. Disease Markers. 12(2). 109–115. 6 indexed citations

18.

El-Ahmady, O., et al.. (1994). TPS IN SERUM AND URINE OF EGYPTIAN BLADDER-CANCER PATIENTS. Oncology Reports. 1(3). 519–21. 2 indexed citations

19.

Motawi, Tarek K., et al.. (1993). Clinical Value of Thymidine Kinase and Tissue Polypeptide Specific Antigen in Breast Cancer. Disease Markers. 11(4). 171–177. 2 indexed citations

20.

Halim, Abdel‐Baset, et al.. (1993). Serum TPS versus TPA in Egyptian Bladder Cancer Patients. The International Journal of Biological Markers. 8(4). 221–226. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact